What you need to know about coronavirus on Tuesday, November 10 #Breaking112
The vaccine uses a never-before-approved technology called messenger RNA, or mRNA, to produce an immune response in people who are vaccinated, which bodes well for other vaccine candidates “using the same platform,” Fauci said.
YOU ASKED. WE ANSWERED
Q: When will we be able to get access to the Pfizer vaccine?
A: If it’s approved for use, a limited number of doses may be available for people by the end of this year. But it won’t be available “in any meaningful way well into the first quarter of next year and then second and third quarter for many people” in America, said Michael Osterholm, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
WHAT’S IMPORTANT TODAY
Brazil suspends trials of China’s Sinovac coronavirus vaccine
An incident reported on October 29 led to the trial being suspended in order to better evaluate the data and assess the risk, according to a note from Brazil’s National Health Surveillance Agency. The note did not provide details on the nature of the serious event or where it took place, citing privacy concerns. Sinovac said in a statement on Tuesday that it was “confident in the safety of the vaccine,” without giving a reason for the reported suspension.
One-fifth of Covid-19 patients get a psychiatric diagnosis within 90 days
In the three months after testing positive for Covid-19, almost one in five survivors (18%) were found to get a psychiatric diagnosis. This is about twice as likely as for other groups of patients with different illnesses and conditions analyzed as part of the study over the same period. “The study reports that patients have a somewhat higher risk of being diagnosed with a psychiatric illness, mainly anxiety or depression, after a Covid-19 diagnosis than after certain other medical events,” said David Curtis, retired consultant psychiatrist and honorary professor at University College London and Queen Mary University of London.
FDA gives emergency OK to Lilly’s antibody treatment for Covid-19
It is the first monoclonal antibody to be authorized for Covid-19 treatment.. The idea is to kick-start an immune response against infection. The authorization was based on a study published in the New England Journal of Medicine in October, which found the treatment seemed to lower the risk of hospitalization and ease some symptoms in a small number of patients.
ON OUR RADAR
- New Zealand’s Chatham Islands might be the only place in the world experiencing overtourism during the pandemic.
- “Lockdown” is Collins Dictionary’s word of the year.
- Two more people in Trump’s orbit, including Housing Secretary Ben Carson, have caught Covid-19.
- The pandemic reimagined sub-Saharan education, but access to digital technology is urgently needed.
- The University of Notre Dame ordered Covid-19 testing for students after fans rushed the field to celebrate a football win.
- Even if a Covid-19 vaccine is released next year, the hotel industry may not recover until 2023.
- The World Health Organization began a global coronavirus meeting– without Covid-19 success story Taiwan.
- A new variant of Covid-19 found in Danish mink farms is disrupting the plans of international football teams for their upcoming matches.
- If different households want to get together indoors, they can all quarantine for 14 days and then get tested.
- That’s going to be very difficult for many people. If that’s not possible, they should see one another outdoors only, with households sitting at least 6 feet apart.
- People should try and reduce nonessential travel.
- Remember things will be better by next Thanksgiving with more vaccines and therapies available. “The best thing we can do for those we love the most may be to not see them, in person, this Thanksgiving.”
“No matter who you voted for, please don’t forget to protect yourself and others from Covid-19.” — CNN’s Chief Medical Correspondent Dr. Sanjay Gupta